Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation. [electronic resource]
Producer: 20150303Description: 994-1006 p. digitalISSN:- 1872-7980
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Asteraceae -- chemistry
- Blotting, Western
- Caspases -- genetics
- Cell Cycle -- drug effects
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase Inhibitor p21 -- genetics
- Endothelium, Lymphatic -- drug effects
- Humans
- Leukocytes, Mononuclear -- drug effects
- Lymphoma, Large-Cell, Anaplastic -- drug therapy
- Mitochondria -- drug effects
- NF-kappa B -- antagonists & inhibitors
- Neoplasm Invasiveness
- Plant Extracts -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-jun -- genetics
- RNA, Messenger -- genetics
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Sesquiterpenes -- pharmacology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.